Compounds and methods for treating diseases mediated by protease activated receptors
- 专利权人:
- Chris Dockendorff
- 发明人:
- Chris Dockendorff,Robert Flaumenhaft,Lawrence MacPherson
- 申请号:
- US13825574
- 公开号:
- US09422262B2
- 申请日:
- 2011.09.23
- 申请国别(地区):
- US
- 年份:
- 2016
- 代理人:
- 摘要:
- The invention relates to the use of a compound of Formula I for the treatment of protease-activated receptor mediated diseases by the administration of a compound of Formula I or a prodrug or metabolite thereof.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
- METHOD FOR TREATING OR MAINTAINING METABOLIC DISTURBANCES USING GLP-1 RECEPTOR AGONATES CONJUGATED WITH GASTRIC INHIBITOR PEPTIDE (GIPR) RECEPTOR ANTAGONISTS
- FORMULATIONS D'ADMINISTRATION PROLONGÉE DE COMPOSÉS DE RISPÉRIDONE
- Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (GIPR)/GLP-1 receptor agonist fusion proteins
- PROGESTERON RECEPTOR MODULATORS FOR APPLICATION IN PREVENTION OR TREATMENT OF DISEASES MEDIATED ANDROGENES